Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 46:1029-1035, doi:10.1016/j.jacc.2005.04.059 (Published online 20 September 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamani, M. H.
Right arrow Articles by Starling, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamani, M. H.
Right arrow Articles by Starling, R. C.

CLINICAL RESEARCH: HEART FAILURE AND CARDIAC TRANSPLANT

Peritransplant Ischemic Injury Is Associated With Up-Regulation of Stromal Cell-Derived Factor-1

Mohamad H. Yamani, MD*,*, Norman B. Ratliff, MD{dagger}, Daniel J. Cook, PhD§, E. Murat Tuzcu, MD*, Yang Yu, MS*, Robert Hobbs, MD*, Gustavo Rincon, MD*, Corinne Bott-Silverman, MD*, James B. Young, MD*, Nicholas Smedira, MD{ddagger} and Randall C. Starling, MD, MPH*

* Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio.
{dagger} Department of Anatomic Pathology, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio.
{ddagger} Department of Cardiothoracic Surgery, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio.
§ Department of Allogen Laboratory, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio.

Manuscript received February 21, 2005; revised manuscript received April 24, 2005, accepted April 25, 2005.

* Reprint requests and correspondence: Dr. Mohamad H. Yamani, Cardiovascular Medicine, F25, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195. (Email: yamanim{at}ccf.org).

OBJECTIVES: We evaluated chimerism and stromal cell-derived factor-1 (SDF-1) expression in response to peritransplant ischemic injury following human heart transplantation.

BACKGROUND: Myocardial ischemia has been shown to trigger mobilization of stem cells to the heart in animal experiments.

METHODS: Between January 1998 and April 2002, a total of 114 male recipients received hearts from female donors. Of these 114 recipients, 26 had evidence of ischemic injury on their initial heart biopsies (ischemia group). These were compared to the remaining 88 patients (control group). Heart biopsy specimens obtained initially at one week and at one year after transplant were evaluated from 20 matched patients of each group for the presence of Y chromosome-containing nuclei. The SDF-1 messenger ribonucleic acid (mRNA) and protein expression were also evaluated on initial heart biopsy specimens.

RESULTS: At one week, Y chromosome-containing nuclei were significantly increased in the ischemia group (0.68% vs. 0.04%; p < 0.0001) compared to the control group. These were positive for the stem cell factor receptor c-kit. A significant 3.3-fold increased mRNA expression (p = 0.001) and 2.8-fold increased protein expression (p = 0.01) of SDF-1 was noted in the ischemia group. At one year, Y chromosome was detected in 0.29% of cardiomyocyte nuclei in the ischemia group but none in the control group. The ischemia group had poorer survival and increased vasculopathy.

CONCLUSIONS: This is the first report to describe chimerism and up-regulation of SDF-1 in human heart transplantation in response to ischemic injury.

Abbreviations and Acronyms
  FISH = fluorescent in situ hybridization
  mRNA = messenger ribonucleic acid
  RT-PCR = reverse transcription-polymerase chain reaction
  SDF-1 = stromal cell-derived factor-1




This article has been cited by other articles:


Home page
FASEB J.Home page
P. J. Hohensinner, C. Kaun, K. Rychli, A. Niessner, S. Pfaffenberger, G. Rega, A. Furnkranz, P. Uhrin, J. Zaujec, T. Afonyushkin, et al.
The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cells
FASEB J, March 1, 2009; 23(3): 774 - 782.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Hegner, M. Lange, A. Kusch, K. Essin, O. Sezer, E. Schulze-Lohoff, F. C. Luft, M. Gollasch, and D. Dragun
mTOR Regulates Vascular Smooth Muscle Cell Differentiation From Human Bone Marrow-Derived Mesenchymal Progenitors
Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 232 - 238.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Schober
Chemokines in Vascular Dysfunction and Remodeling
Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 1950 - 1959.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. Hu, S. Dai, W.-J. Wu, W. Tan, X. Zhu, J. Mu, Y. Guo, R. Bolli, and G. Rokosh
Stromal Cell Derived Factor-1{alpha} Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell Derived Factor-1{alpha} CXCR4 Axis
Circulation, August 7, 2007; 116(6): 654 - 663.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. Segret, C. Rucker-Martin, C. Pavoine, J. Flavigny, E. Deroubaix, M.-A. Chatel, A. Lombet, and J.-F. Renaud
Structural Localization and Expression of CXCL12 and CXCR4 in Rat Heart and Isolated Cardiac Myocytes
J. Histochem. Cytochem., February 1, 2007; 55(2): 141 - 150.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement